HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shengqin Cheng Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

1/2022PD-1 Checkpoint Blockade in Patients for Acute Myeloid Leukemia after HSCT Relapse Resulted in Severe GVHD and sHLH.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shengqin Cheng Research Topics

Disease

1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2022
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2022
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022
1Pancreatitis
01/2020
1Vomiting
01/2020
1Abdominal Pain (Pain, Abdominal)
01/2020

Drug/Important Bio-Agent (IBA)

1DecitabineFDA Link
07/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Asparaginase (Elspar)FDA Link
01/2020
1antiarrhythmic peptide (AAP)IBA
01/2020

Therapy/Procedure

2Therapeutics
07/2022 - 01/2020
1Remission Induction
07/2022